Jill Feldman: The profound impact of a Lung Cancer diagnosis
Jill Feldman, Co-Founder of EGFR Resisters and Lung cancer Patient and Advocate, shared her recent article on LinkedIn:
“The physician’s duty is not to stave off death or return patients to their old lives, but to take into our arms a patient and family whose lives have disintegrated and work until they can stand back up and face—and make sense of—their own existence” — Paul Kalanithi, MD
I appreciate the opportunity to co-author this important article.
The piece emphasizes the profound impact of a lung cancer diagnosis, shining a light on the multifaceted challenges patients & families face – medical, psychosocial, social & financial burdens. It underscores the need for a holistic approach to lung cancer care that extends far beyond clinical treatment.
These critical conversations will shape the future of humane, compassionate cancer care. While we’ve made tremendous progress, there is still so much more to do! We must work together to transform what was once seen as a “one-way ticket” into an experience filled with hope, support, and compassionate care.”
Authors: Drew Moghanaki, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023